Fluorescence-guided Resection of Experimental Malignant Glioma Using Cetuximab-IRDye 800CW

The standard treatment for Glioblastoma Multiforme (GBM) remains maximal safe surgical resection. Here, we evaluated the ability of a systemically administered antibody-dye probe conjugate (cetuximab-IRDye 800CW) to provide sufficient fluorescent contrast for surgical resection of disease in both su...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Br J Neurosurg
Autores principales: Warram, Jason M., de Boer, Esther, Korb, Melissa, Hartman, Yolanda, Kovar, Joy, Markert, James M., Gillespie, G. Yancey, Rosenthal, Eben L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4740249/
https://ncbi.nlm.nih.gov/pubmed/26073144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02688697.2015.1056090
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares